Nu Skin Enterprises Inc. (NYSE:NUS) Director Andrew D. Lipman sold 30,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Thursday, September 22nd. The shares were sold at an average price of $64.13, for a total transaction of $1,923,900.00. Following the transaction, the director now directly owns 36,090 shares of the company’s stock, valued at $2,314,451.70. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Shares of Nu Skin Enterprises Inc. (NYSE:NUS) opened at 63.12 on Friday. The firm’s 50-day moving average is $59.04 and its 200 day moving average is $46.28. The firm has a market cap of $3.53 billion, a PE ratio of 36.21 and a beta of 1.75. Nu Skin Enterprises Inc. has a 52 week low of $23.51 and a 52 week high of $64.48.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.79 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.01. Nu Skin Enterprises had a return on equity of 18.46% and a net margin of 4.52%. The firm earned $600.05 million during the quarter, compared to the consensus estimate of $578.87 million. During the same period last year, the company earned $0.75 earnings per share. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. Equities research analysts forecast that Nu Skin Enterprises Inc. will post $2.88 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 14th. Shareholders of record on Friday, August 26th were given a $0.355 dividend. This represents a $1.42 annualized dividend and a yield of 2.25%. The ex-dividend date of this dividend was Wednesday, August 24th. Nu Skin Enterprises’s payout ratio is 81.14%.
NUS has been the subject of several recent research reports. Jefferies Group initiated coverage on shares of Nu Skin Enterprises in a report on Friday, June 3rd. They set a “hold” rating and a $41.00 target price for the company. Pivotal Research lifted their target price on shares of Nu Skin Enterprises from $55.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, June 16th. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $52.00 target price for the company in a report on Tuesday, June 21st. Citigroup Inc. lifted their target price on shares of Nu Skin Enterprises from $45.00 to $52.00 and gave the company a “buy” rating in a report on Friday, July 1st. Finally, Deutsche Bank AG reissued a “hold” rating and issued a $55.00 price target (up previously from $45.00) on shares of Nu Skin Enterprises in a report on Sunday, July 24th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Nu Skin Enterprises has a consensus rating of “Hold” and a consensus price target of $50.72.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Metropolitan Life Insurance Co. NY boosted its position in Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock valued at $109,000 after buying an additional 77 shares during the last quarter. Parametrica Management Ltd acquired a new position in Nu Skin Enterprises during the second quarter valued at about $207,000. M&T Bank Corp acquired a new position in Nu Skin Enterprises during the second quarter valued at about $209,000. CIBC World Markets Inc. acquired a new position in Nu Skin Enterprises during the second quarter valued at about $211,000. Finally, Hsbc Holdings PLC acquired a new position in Nu Skin Enterprises during the second quarter valued at about $214,000. Hedge funds and other institutional investors own 77.08% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.